Back to search

France· FR:69443489

STEROGYL 15 "A" 600 000 UI/1,5 ml, solution buvable en ampoule

A ergocalciferol product containing ergocalciférol, registered in France by DESMA PHARMA, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A11CC01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSTEROGYL 15 "A" 600 000 UI/1,5 ml, so…ATCA11CC01REGISTER NO.FR:69443489PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Ergocalciferol is registered in 7 of 19 countries.

Countries holding a registration under ATC A11CC01 (ergocalciferol), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose

Ergocalciferol · ATC A11CC01

7 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ERGOCALCIFÉROL
Manufacturer
DESMA PHARMA
Country
France (FR)
ATC code
A11CC01
ATC class
Ergocalciferol
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930998328
    1 ampoule(s) en verre jaune(brun) de 1,5 ml
    EUR 1.42

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for ergocalciferol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ergocalciferol · interactions on record

68 records

  • 10 severe
  • 56 moderate
  • 2 minor

Most severe, free to view

  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • ColecalciferolA11CC05severe
  • CalcifediolA11CC06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ergocalciferol in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ergocalciferol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Czechia · Calciferol Bbp
  • United Kingdom (Northern Ireland) · Ergocalciferol Rph Pharmaceuticals
  • Slovakia · Calciferol Bbp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a1a69518-c655-45a1-a4a7-9c51401fcc53
GET /v1/drugs/a1a69518-c655-45a1-a4a7-9c51401fcc53?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69443489",
  "date_amm": "1997-03-21",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ERGOCALCIFÉROL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ergocalciferol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.